aica ribonucleotide and Leukemia, Myeloid, Acute

aica ribonucleotide has been researched along with Leukemia, Myeloid, Acute in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, L; Han, F; Qu, H; Ren, L; Yan, H; Yang, S1
Banfic, H; Dembitz, V; Lalic, H; Lukinovic-Skudar, V; Visnjic, D1

Other Studies

2 other study(ies) available for aica ribonucleotide and Leukemia, Myeloid, Acute

ArticleYear
Combination therapy with 5-amino-4-imidazolecarboxamide riboside and arsenic trioxide in acute myeloid leukemia cells involving AMPK/TSC2/mTOR pathway.
    Die Pharmazie, 2013, Volume: 68, Issue:2

    Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Blotting, Western; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Synergism; HL-60 Cells; Humans; Hypoglycemic Agents; Leukemia, Myeloid, Acute; Oxides; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; Ribonucleotides; Signal Transduction; TOR Serine-Threonine Kinases; Tuberous Sclerosis Complex 2 Protein; Tumor Suppressor Proteins

2013
5-Aminoimidazole-4-carboxamide ribonucleoside induces differentiation of acute myeloid leukemia cells.
    Leukemia & lymphoma, 2014, Volume: 55, Issue:10

    Topics: Aminoimidazole Carboxamide; Apoptosis; Cell Differentiation; Cell Line, Tumor; Humans; Leukemia, Myeloid, Acute; Mitogen-Activated Protein Kinases; Ribonucleotides; Signal Transduction; Tumor Cells, Cultured

2014